Advertisement

Gastroenterologia Japonica

, Volume 24, Issue 3, pp 315–319 | Cite as

A case report of transcatheter arterial embolization of cholestatic type of hepatoma

  • Hitoshi Takagi
  • Masahiro Uehara
  • Shigeyuki Katakai
  • Shoji Yamada
  • Takehiko Abe
  • Jiro Takezawa
  • Takeaki Nagamine
  • Kunio Ichikawa
  • Setsuo Kobayashi
Case Report
  • 9 Downloads

Summary

A 57-year-old man with hepatocellular carcinoma (HCC) invading the hepatic duct was treated with transcatheter arterial embolization (TAE). The dilated hepatic duct was decompressed his jaundice disappeared and he survived for 10 months after the first TAE, succumbing due to bleeding from gastric erosion. Although total bilirubin was 26.7 mg/dl and massive ascites was noted on occasion of the first TAE, hepatic dysfunction did not worsen and both icterus and ascites decreased, disappearing one month after the therapy. Autopsy revealed HCC with trabecular arrangement originating in the left lobe and growing into the left hepatic duct accompanied by liver cirrhosis and follicular carcinoma of the thyroid gland. Severe icterus caused by bile duct obstruction does not correlate with the grade of hepatic failure in HCC with liver cirrhosis, so TAE was effective and should be tried as a first choice therapy in such a poor risk case.

Key words

cholestatic type of hepatoma hepatocellular carcinoma (HCC) transcatheter arterial embolization (TAE) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397–401PubMedGoogle Scholar
  2. 2.
    Okuda K, Nakashima t: Primary carcinoma of the liver. In: Haubrich WS et al, ed. Bockus Gastroenterology. WB Saunders Philadelphia 1985;3346Google Scholar
  3. 3.
    Kojiro M, Kawabata K, Kawano Y, et al: Primary carcinoma presenting as intra-bile duct tumor growth. A clinicopathologic study of 24 cases. Cancer 1982;49:2144–2147PubMedCrossRefGoogle Scholar
  4. 4.
    Okuda K and the liver cancer study group of Japan: Primary liver cancers in Japan. Cancer 1980;45:2663–2669CrossRefGoogle Scholar
  5. 5.
    Taguchi H, Ogino R, Miyata A, et al: Two cases of hepatocellular carcinoma with a intrabiliary growth. Jpn J Gastroenterol. 1983;80:2259–2268(in Jpn)Google Scholar
  6. 6.
    Tsuzuki T, Ogata Y, Iida S, et al: Hepatoma with obstructive jaundice due to the migration of a tumor mass in the biliary tract: Report of a successful resection. Surgery 1979;85:593–598PubMedGoogle Scholar
  7. 7.
    Yamada R: Today’s TAE therapy. Jap J Clin Surg 1985;39:939–941 (in Jpn)Google Scholar
  8. 8.
    Kimura M, Ohto M, Tsuchiya Y: Transcatheter arterial embolization to the hepatoma and its evaluation. Jpn J Gastroenterology 1983;80:68–75(in Jpn)Google Scholar
  9. 9.
    Tsuda M, Satoh M, Yamada R, et al: The role of anti neoplastic solution in transcatheter hepatic arterial embolization. Cancer therapy. 1988;23:229Google Scholar
  10. 10.
    Molnar W, Stockum AE: Relief of obstructive jaundice through percutaneous transhepatic catheter -A new therapeutic method. AJR 1974;122:356–367Google Scholar

Copyright information

© The Japanese Society of Gastroenterology 1989

Authors and Affiliations

  • Hitoshi Takagi
    • 1
  • Masahiro Uehara
    • 1
  • Shigeyuki Katakai
    • 1
  • Shoji Yamada
    • 2
  • Takehiko Abe
    • 2
  • Jiro Takezawa
    • 2
  • Takeaki Nagamine
    • 2
  • Kunio Ichikawa
    • 2
  • Setsuo Kobayashi
    • 2
  1. 1.Department of Internal MedicineMaebashi Red Cross HospitalMaebashiJapan
  2. 2.First Department of Internal MedicineGunma University School of MedicineMaebashiJapan

Personalised recommendations